Cite
HARVARD Citation
Derks, M. et al. (n.d.). Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. Lancet oncology. 18 (9), pp. 1211-1220. [Online].